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SUMMARY
The aim of the present study was to perform a retrospective review, from 1932 to 1999, in order to establish the number
of cases of mammary tumors in dogs in the records at the Pathology Department of Faculdade de Medicina Veterinária
– USP, as well as the presence of desmoplasia and cartilaginous and bone metaplasia in 578 of these tumors. Among the
537 malignant tumors, 13.05% were simple tubular adenocarcinomas, 3.91% were complex tubular adenocarcinomas,
7.26% simple papillary adenocarcinomas, 4.28% complex papillary adenocarcinomas , 23.27% simple papillary
cystadenocarcinomas ,8.37% complex papillary cystadenocarcinomas,16.38% simple solid adenocarcinomas ,6.70%
complex solid adenocarcinomas, 2.04% simple spindle cell carcinomas, 1.11% simple spindle cell carcinomas ,2.79%
mucinous carcinomas ,8.19% anaplastic carcinomas ,0.93% squamous carcinomas, 1.30% fibrosarcomas,.0.18%
chondrosarcoma, 0.18% osteosarcoma and among the 41 benign tumors ,51.21% were adenoma, 12.19% papillary
cystadenoma,7.31% papilloma, 4.87% cystic fibroadenoma and 24.39% were  fibroadenoma. Both desmoplasia and
metaplasia were frequent findings in benign and malignant neoplasms, but they were more frequent among complex
tubular adenocarcinomas: 38% presented desmoplasia, 57% cartilaginous metaplasia and 28% bone metaplasia. Among
the benign neoplasms, adenoma presented  the more frequency: 14 % presented  desmoplasia, 29% cartilaginous
metaplasia and 24% bone metaplasia. Results of this study emphasize the complexity of the inter-relationship between
the macromolecules in the extracellular matrix and tumoral cells.
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INTRODUCTION
Mammary tumors are frequent in dogs, and theycorrespond to 25% of the neoplasms in thisspecies8. The variety of histological types has
produced conflicting concepts related to classification and
histogenesis, what resulted in a variety of taxonomic systems.
Mammary neoplasms in dogs that are similar to those in
humans16,20,22 are of special concern to the oncology
researchers because they may be used as biological models in
the search for more precocious diagnoses, more exact prognoses
and a more efficient therapeutic procedures.
In the present trial, 1,371 cases of alterations in the
mammary glands of dogs were analyzed and 578 specimens
were studied. These cases are part of the records in FMVZ /
USP from 1936, when the school was founded, to 1999.
Classification used was that of the World Health Organization
(WHO), adapted by Hampe and Misdorp7 , which is based on
descriptive morphology and histogenesis. Neoplasms were
described as complex when secretory and myoepithelial cells
were altered. They were described as simple when only one of
the cell types was modified. Both simple and complex carcinomas
were classified according to the level of differentiation of the
tubules. Tubular adenocarcinomas are placed at one of the
extremes, and anaplastic carcinomas, at the other.
Mammary neoplasms frequently present abundant
extracellular matrix (ECM), called desmoplasia8. In dogs, it is
common to observe cartilaginous and bone metaplasia8.
The objective of the present trial was to reclassify benign
and malignant neoplasms in dogs, according to the WHO
guidelines, in order to determine the number of cases as well as
the frequency of desmoplasia and cartilaginous and bone
metaplasia in the specimens analyzed.
MATERIAL AND METHOD
Blocks and slides with benign and malignant tumors
of dogs were used in this trial. A total of 578 cases from the
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records in the Animal Pathology Sector at the Pathology
Department in Faculdade de Medicina Veterinária e
Zootecnia / USP, from 1936 to 1999 were analyzed.  Cuts
were obtained from the blocks and were 5 mm thick. They
were stained by hematoxilyn and eosin  for the identification
of the histological types.
RESULTS
From de microscopic analysis of 1,371 cases of alterations
in the mammary gland, according to the morphological
characteristics of benign and malignant tumors, from the records
in the Animal Pathology Sector at the Pathology Department in
Faculdade de Medicina Veterinária e Zootecnia / USP, from
1936 to 1999, the following number of cases was found: 1,249
cases malignant neoplams, 111 benign neoplasms and 11 cases
of mammary duct hyperplasia. In the analysis of the malignant
neoplasms, according to their histogenesis,  1,227 carcinoma
cases and  22 sarcoma cases were found.
For the reclassification of each case, according to
WHO, 578 specimens were used, for many slides were
deteriorated and / or the material in the blocks was not
representative.
The results of the study are presented in tab. 1, 2, 3
and 4 and fig., as follows:
No. of Type %
 cases
70 Simple tubular adenocarcinomas 13.05
21 Complex tubular adenocarcinomas 3.91
39 Simple papillary adenocarcinomas 7.26
23 Complex papillary adenocarcinomas 4.28
125 Simple papillary cystadenocarcinomas 23.27
45 Complex papillary cystadenocarcinomas 8.37
88 Simple solid adenocarcinomas 16.38
36 Complex solid adenocarcinomas 6.70
11 Simple spindle cell carcinomas 2.04
6 Complex spindle cell carcinomas 1.11
15 Mucinous carcinomas 2.79
44 Anaplastic carcinomas 8.19
5 Squamous carcinomas 0.93
7 Fibrosarcomas 1.30
1 Chondrosarcoma 0.18
1 Osteosarcoma 0.18
Table 1
Number of cases of the several types of mammary gland malignant
neoplasms in dogs studied in the records of the Pathology Department
at FMVZ-USP from March, 1936 to October, 1999, according to
WHO classification.
Total:  537         92.90 %   were malignant
No. of cases Types %
21 Adenoma 51.21
5 Papillary cystadenoma 12.19
3 Papilloma 7.31
2 Cystic fibroadenoma 4.87
10 Fibroadenoma 24.39
Table 2
 Histological types of benign neoplasms in the mammary gland of
dogs in the records of the Pathology Department at FMVZ-USP
from March, 1936 to October, 1999, according to WHO classification.
Total:  41  7.09% were benign
Table 3
Percentile analysis of desmoplasias, cartilaginous and bone metaplasias observed in mammary carcinomas in dogs, found in the
Pathology Department at FMVZ-USP from March, 1936 to October, 1999.
Type Desmoplasia Cartilaginous Metaplasia Bone Metaplasia
Tubular adenocarcinoma S 32 % 22 % 9 %
Tubular adenocarcinoma C 38 % 57 % 28 %
Papillary adenocarcinoma S 23 % 33 % 10 %
Papillary adenocarcinoma C 22 % 26 % 9 %
Papillary cystadenocarcinoma S 25 % 33 % 19 %
Papillary cystadenocarcinoma C 19 % 36 % 7 %
Solid adenocarcinoma S 16 % 14 % 4 %
Solid adenocarcinoma C 17 % 28 % 3 %
Spindle cells S 27 % 36 % 18 %
Spindle cells C 17 % 17 % 0 %
Mucinous carcinoma 18 % 9 % 0 %
Anaplastic carcinoma 14 % 23 % 15 %
Squamous carcinoma 25 % 25 % 25 %
S= simple     C= complex
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and liposarcomas . In the series of observations performed
in the present trial, carcinosarcomas were not considered,
for the origin of the altered cells is myoepithelial and not
fibroblastic 5,17. Simple and complex mammary carcinomas
were present in 65% and 35 % of the cases, respectively.
Mammary neoplasms frequently present an abundant
amount of extracellular matrix, which is called desmoplasia.
It could be noted, from the analysis of carcinomas and benign
neoplasms in relation to the presence of desmoplasia, that
complex tubular adenocarcinoma presented it more
frequently (38%). The lower frequency was found in
anaplastic carcinoma (14%). Desmoplasia is increased in
mammary carcinomas probably as a result of the secretion,
by the tumoral cells, of factors known as mesenchymal cell
biosynthetic activity modulators, such as TGFb , TGFa ,
PDGF, FGF23,18,10; due to the secretion of a 68 kDa polypeptide
which increases collagen synthesis in other cells, including
fibroblasts4 and other biosynthesis products from tumoral
cells which modulate the renewal of ECM macromolecules
responsible for the regulation of the synthesis or degradation,
or both. This altered matrix, in its turn, may influence several
tumoral functions such as morphology13,14,15 differentiation,
binding, metastasis potential and biosynthesis activity9. This
altered matrix would act on myoepithelial cells, which, in
their turn, would have a paracrinous effect on glandular
epithelium, regulating tumor progression and accumulating,
more than degrading, the ECM (they present low expression
of proteinases and high expression of proteinase inhibitors).
These cells also contribute for the synthesis of basal
membrane, inhibit angiogenesis and express a great amount
of maspim, a tumor suppresser21 . In mammary neoplasms,
desmoplasia may occur due to the action of tumoral and
myoepithelial cells. According to21, myoepithelial cells,
besides their contractile function and their role in the
synthesis and remodeling of basal membrane, may also
regulate growth, differentiation and morphogenesis of
neighboring, epithelial and mesenchymal cells, for they
secrete growth factors and cytokines such as TGFb , TGFa
and interleukin6. With the increase of gene instability, from
tubular adenocarcinoma to anaplastic carcinoma, epithelial
cells would secrete a larger quantity of these modulators for
DISCUSSION AND CONCLUSIONS
Based on the results, it is observed that the frequency
of these kind of tumors in dogs in the records of the
Pathology Department in the Faculdade de Medicina
Veterinária e Zootecnia - USP, from 1936 to 1999 is variable,
as well as the expression of the extracellular matrix in 578
these different histological types of carcinomas and benign
neoplasms .The percentile of benign tumors (7.09 %) is novel
information, for it was not found in the specialized literature
studied 11,12. The justification may be attributed to the fact
that the authors, in general, have used a small universe for
the determination of the number of cases. Non-neoplasic
proliferative lesions have been observed in only 1 % of the
1,371 cases studied, information that was not found in the
literature. In relation to histogenesis, 98% of 1,249 malignant
tumors were carcinomas. The other 2 % were mesenchymal
tumors in the tissue of the mammary gland: osteosarcomas
(19%), chondrosarcomas (9%), fibrosarcomas (67%) and
liposarcoma (5%). Among the 537 different histological types
of malign neoplasms reclassified, however, 7 cases were
fibrosarcoma (1.30%), 1 chondrosarcoma (0.18%) and 1
osteosarcoma (0.18%) In relation to this, it may be inferred
that myoepithelial cells are responsible for condroblast and
osteoblast tumors, and may also be transformed in
chondrosarcomas and osteosarcomas. Fibroblasts and
lipoblasts, on the other hand, when undergoing malignant
transformation would generate, respectively, fibrosarcomas
Table 4
Percentile analysis of desmoplasias, cartilaginous and bone metaplasias observed in mammary benign neoplasms in dogs, found in the
Pathology Department at FMVZ-USP from March, 1936 to October, 1999.
Figure l
Percentile distribution of the different types of mammary sarcoma
in dogs found in the records of the Pathology Department at
FMVZ-USP from March, 1936 to October, 1999.
Types Desmoplasia Cartilaginous metaplasia Bone Metaplasia
Cistadenenoma 0 % 20 % 20 %
Adenoma 14 % 29 % 24 %
Papillary adenoma 0 % 33 % 0 %
Fibroadenoma 10 % 20 % 10 %
Cystic papillary fibroadenoma 0 % 50 % 0 %
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expression of collagen XI enables the expression of collagen
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homology between complementary DNA and aminoacid
sequence of the suppresser gene and that of collagen type II
and IX specific of chondrocytes. Myoepithelial cells express
TGFb and other members of the TGFb family such as bone
morphogenetic proteins, including osteogenin and osteogenic
proteins know as bone / cartilage inducing factors19.
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specialized literature, that the expected higher frequency of
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gene instability in neoplasic cells during the progression of
tumors and their influence on myoepithelial cells would make
them lose their suppressing activity.
3. ARAI, K.; UEHARA, K.; NAGAI, Y. Simultaneous expression of type
IX collagen and inhibit – related antigen in proliferative myoepithelial
cells with pleomorphic adenoma of canine mammary glands. Japanese
Journal of Cancer Research, v. 86, n.6, p. 577–584, 1995.
4. BANO, M.; SALOMON, D. S.; KIDWELL, W. R. Purification of
a mammary derived growth factor from human milk and human
mammary tumors. Biological Chemistry, v. 260, n.9, p. 5745-
5752, 1985.
MARTINS, A.M.C.R.P.F.; TAMASO, E.; GUERRA, J.L. Retrospective review and systematic study of mammary tumors in dogs and characteristics
of the extracellular matrix Braz. J. vet. Res. anim. Sci., São Paulo, v.39, n.1, p. 38-42, 2002.
4 2
15. NÖEL, A.; MUNAUT, C.; NUSGENS, B.; FOIDART, J. M.;
LAPIERE, C. M. The stimulation of fibroblasts collagen-synthesis
by neoplastic cells is modulated by the extracellular-matrix. Matrix,
v.12, n. 3, p. 213-220, 1992.
16. PIERREPOINT, C. G. Possible benefits to veterinary medicine
of considering the dog as a model for human cancer. Journal of
Small Animal Practice , v. 26, n.1, p. 43-47, 1985.
17. PULLEY , L. T. Ultrastructural and histochemical demonstration
of myoepithelium in complex tumor of the canine mammary gland.
American Journal of Veterinary Research, v. 34, n. 12, p.1513-
1522, 1973.
18. ROSS, R. ; RAINES, E. W.; BOWEN–POPE, D. F. The biology
of platels - derived growth factor. Cell , v. 46, n. 2, p 155–169,
1986.
19. SAMPATH, T. H.; COUGHLIN, J. E.; WHETSONE, R. M.;
BANACH, D.; CORBETT, C.; RIDGE, R. J.; OEZAYNAK, E.;
OPPERMANN, H; RUEGER, D. C. Bovine osteogenic proteins is
composed of dimers of OP- 1 and BMP –2A , two members of the
transforming growth factor –beta super-family. Journal of
Biological Biochemistry, v. 265, n. 22, p. 1198-1205, 1990.
20. SCHNEIDER, R.. Comparison of age, sex and incidence rater in
human and canine breast cancer. Cancer, v. 26, n. 2, p. 419-426,
1970.
21. STERNLICH, M. D.; BARSKY, S. H.  The myoepithelial defense:
a host defense against cancer. Medical Hypotheses, v. 48, n.1, p.
37–46, 1997.
22. STRANDBERG, J. D.; GOODMAN, D. G. Animal mode of human
disease. Breast cancer. American Journal of Pathology, v .75, n.
1, p. 225-28, 1974.
23. VARGA, J.; ROSENBLOOM, J.; JIMENEZ, S. A.  Transforming
growth factor b (TGFb) causes a persistent increase in steady stade
amounts of type I and type III collagen and fibronectin mRNAs in
normal human dermal fibroblasts. Biochemistry Journal, v. 247,
p. 597-604, 1987.
5. BOMHARD, D. E.; SANDERSL, J. V. Ultrastructure of mixed
mammary-gland tumors in bitches. I. Incidence of myoepithelial
cells in myxoid areas. Virchows Archiv A. Pathological Anatomy
and Histology, v. 359, n. 1, p. 87-96, 1973.
6. BOMHARD, D. E; SANDERSL, J. V. Ultrastructure of mixed
mammary-gland tumours in bitches. II. Incidence of myoepithelial
cells in chondroid areas. Virchows Archiv A. Pathological
Anatomy and Histology, v. 362, n. 2, p. 157-167, 1974.
7. HAMPE, J. F.; MISDORP, W. Tumors and dysplasias of the
mammary gland. Bulletin of the World Health Organization,
v. 50, n. 1-2, p. 111-133, 1974.
8. JONES, T. C ;HUNT, R.D. ; KING, N.W.- Veterinary pathology.
6. ed.  Philadelphia:Lippincott Williams & Wilkins, 1997, pg 89,
1192-1996
9. KLEINMAN, H .K.; CANNON, F. B.; LAURIE, G. W; HASSELL,
J. R.; AUMAILLEY, M.; TERRANOVA, V. P.; MARTIN, G. R.;
DUBOIS-DALCQ. Biological activities of laminin.  Journal of
Cellular Biochemestry, v. 27, n.4, p. 317-325, 1985.
10. MARTINEZ-HERNANDEZ, A.  The extracellular matrix and
neoplasia. Laboratory Investigation, v. 58, n. 6, p. 609-612, 1988.
11. MOULTON, J. E.; ROSENBLATT, L. S.; GOLDMAN, M.
Mammary tumours in a colony of beagle dogs. Veterinary
Pathology, v. 23, n. 6, p. 741-749, 1986.
12. NERURKAR, V. R.; CHITALE, A. R.; JANAPURKAR, B. V.;
NAIK, S. N.; LALITHA, V. S. Comparative pathology of canine
mammary tumors. Journal of Comparative Pathology, v. 101,
n. 4, p. 389-397, 1989.
13. NÖEL, A.; CALLÉ, A.; EMONARD, H.; NUSGEN, B.;
FOIDART, J. M.; LAPIERE, C. M. Antagonist effects of laminine
and fibronectin in cell – to – cell and cell – to -matrix in MCF – 7
cultures. In Vitro Cellular and Developmental Biology, v. 25,
n. 5, p. 373-379, 1988.
14. NÖEL, A.; MUNAUT, C.; NUSGENS, B.; FOIDART, J. M.;
LAPIERE, C. M. Different mechanisms of extracellular matrix
remodeling by fibroblasts in response to human mammary neoplastic-
cells. Invasion & Metastasis, v. 13, n. 2, p.72-81, 1993. Received: 13/08/2001Accepted: 31/01/2002
MARTINS, A.M.C.R.P.F.; TAMASO, E.; GUERRA, J.L. Retrospective review and systematic study of mammary tumors in dogs and characteristics
of the extracellular matrix Braz. J. vet. Res. anim. Sci., São Paulo, v.39, n.1, p. 38-42, 2002.
